Variant report
Variant | nsv965364 |
---|---|
Chromosome Location | chr3:146570227-146584347 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:146543043..146545819-chr3:146575097..146577219,2 | MCF-7 | breast: | |
2 | chr3:146568702..146571051-chr3:146573084..146575725,2 | K562 | blood: | |
3 | chr3:146570466..146572566-chr3:146575792..146578256,3 | K562 | blood: | |
4 | chr3:146568702..146571051-chr3:146573084..146575725,2 | K562 | blood: | |
5 | chr3:146570466..146572566-chr3:146575792..146578256,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs144664688 | chr3:146572266-146572267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs532245575 | chr3:146572274-146572275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs372378949 | chr3:146572319-146572320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs552056895 | chr3:146572321-146572322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs551368991 | chr3:146572408-146572409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185741898 | chr3:146572432-146572433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189349121 | chr3:146572469-146572470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs370092636 | chr3:146572505-146572506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548493859 | chr3:146572535-146572536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs7630260 | chr3:146572562-146572563 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs116209515 | chr3:146572582-146572583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs62273051 | chr3:146572643-146572644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547777189 | chr3:146572685-146572686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs375141548 | chr3:146572721-146572722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570821066 | chr3:146572725-146572726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs79270469 | chr3:146572735-146572736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556268899 | chr3:146572737-146572738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569902001 | chr3:146572746-146572747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs117541486 | chr3:146572760-146572761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs1521588 | chr3:146572777-146572778 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs369215397 | chr3:146572859-146572860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs7349522 | chr3:146572888-146572889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181605084 | chr3:146572907-146572908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs4681340 | chr3:146572919-146572920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs576790836 | chr3:146572965-146572966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs545867310 | chr3:146572979-146572980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs7642381 | chr3:146572988-146572989 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs11917944 | chr3:146572991-146572992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs7642386 | chr3:146572999-146573000 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs542046350 | chr3:146573010-146573011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561920602 | chr3:146573033-146573034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs185930677 | chr3:146573100-146573101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs190598391 | chr3:146573203-146573204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs534931029 | chr3:146573245-146573246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs570805758 | chr3:146573271-146573272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs533207139 | chr3:146573297-146573298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs549856108 | chr3:146573304-146573305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs569864987 | chr3:146573328-146573329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs75242792 | chr3:146573330-146573331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs200438808 | chr3:146573331-146573332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs535607527 | chr3:146573352-146573353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553571572 | chr3:146573364-146573365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs201785152 | chr3:146573365-146573366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs549569087 | chr3:146573436-146573437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs565791477 | chr3:146573441-146573442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145361624 | chr3:146573445-146573446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs566209070 | chr3:146573486-146573487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs181593663 | chr3:146573502-146573503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs149201543 | chr3:146573574-146573575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs569573991 | chr3:146573655-146573656 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Colorectal cancer | 18645599 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Autism | 18923514 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Autism | 21956041 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:146572200-146572400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr3:146572400-146572600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr3:146572600-146580400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr3:146573600-146574000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr3:146580400-146580600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr3:146580600-146581000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr3:146580600-146583600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr3:146581000-146581200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr3:146581200-146582400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr3:146582200-146583400 | Enhancers | Fetal Heart | heart |
11 | chr3:146582200-146583600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
12 | chr3:146582400-146583200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr3:146582600-146583400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr3:146583000-146583400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
15 | chr3:146583200-146583600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |